Trial shows Oxford-developed COVID-19 vaccine offers only “minimal” protection against mild to moderate illness from South Africa variant. Source
Trial shows Oxford-developed COVID-19 vaccine offers only “minimal” protection against mild to moderate illness from South Africa variant. Source